EX-99.A 2 ex99_a.htm EXHIBIT A

Exhibit A
 
JOINT FILING AGREEMENT
 
This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of shares of Common Stock, $0.001 par value per share, of BridgeBio Pharma Inc., is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below that is named as a reporting person in such filing in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Dated: July 10, 2019
     
       
 
KKR GENETIC DISORDER L.P.
 
By: KKR Genetic Disorder GP LLC, its general partner
 
       
 
By:
/s/
Terence Gallagher
 
 
Name:
Terence Gallagher
 
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
 
       
 
KKR GENETIC DISORDER GP LLC
       
 
By:
/s/
Terence Gallagher
 
 
Name:
Terence Gallagher
 
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
 
       
 
KKR MANAGEMENT HOLDINGS L.P.
 
By: KKR Management Holdings Corp., its general partner
       
 
By:
/s/
Terence Gallagher
 
Name:
Terence Gallagher
 
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
 


 
KKR MANAGEMENT HOLDINGS CORP.
     
 
By:
/s/
Terence Gallagher
 
Name:
Terence Gallagher
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
     
 
KKR GROUP HOLDINGS CORP.
     
 
By:
/s/
Terence Gallagher
 
Name:
Terence Gallagher
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
     
 
KKR & CO. INC.
     
 
By:
/s/
Terence Gallagher
 
Name:
Terence Gallagher
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
     
 
KKR MANAGEMENT LLC
     
 
By:
/s/
Terence Gallagher
 
Name:
Terence Gallagher
 
Title:
Attorney-in-fact for William J. Janetschek, Chief Financial Officer
     
 
HENRY R. KRAVIS
     
 
By:
/s/
Terence Gallagher
 
Name:
Terence Gallagher
 
Title:
Attorney-in-fact
     
 
GEORGE R. ROBERTS
   
 
By:
/s/ Terence Gallagher
 
Name:
Terence Gallagher
 
Title:
Attorney-in-fact